Optimization of a siRNA Carrier Modified with a pH-Sensitive Cationic Lipid and a Cyclic RGD Peptide for Efficiently...

Area of Science:

• Oncology
• Nanomedicine
• Biotechnology

Background:

• Anti-angiogenic therapy shows promise for various cancers but faces challenges due to severe adverse events in normal tissues.
• Targeted drug delivery systems (DDS) are crucial for enhancing anti-angiogenic therapy efficiency and minimizing toxicity.
• Tumor endothelial cells (TECs) overexpress αVβ₃ integrin, a target for specific ligand-based delivery.

Purpose of the Study:

• To optimize the preparation conditions and components of the cyclic RGD-equipped liposomal DDS (RGD-MEND) for efficient delivery to TECs.
• To investigate the impact of ligand density, PEG linker length, and lipid composition on RGD-MEND performance.
• To enhance the anti-angiogenic therapeutic efficacy of RGD-MEND with minimal toxicity.

Main Methods:

• Systematic exploration of RGD-MEND preparation parameters, including ligand density, poly(ethyleneglycol) linker length, and lipid composition.
• Evaluation of cellular uptake and gene silencing capabilities of optimized RGD-MEND formulations.
• Comparison of the efficacy of the optimized RGD-MEND with previous formulations.

Main Results:

• Optimized RGD-MEND preparation yielded a five-fold increase in knockdown efficiency compared to previous studies.
• The optimized formulation demonstrated significantly improved cellular uptake and therapeutic effect.
• Achieved an ED50 value of 0.75 mg/kg, a substantial improvement from the previous 4.0 mg/kg.

Conclusions:

• The optimized RGD-MEND formulation represents a significant advancement in targeted anti-angiogenic drug delivery.
• This DDS shows potential for highly efficient cancer treatment with reduced systemic toxicity.
• Further development of RGD-MEND could lead to improved therapeutic strategies for various cancers.